Azenta, Inc. (AZTA)
NMS · Healthcare · Medical Instruments & Supplies
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About Azenta, Inc.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 143.9M | 159.0M | 148.6M | 144.8M |
| Gross Profit | 67.8M | 68.0M | 63.7M | 62.0M |
| Operating Income | 40K | 1.8M | -6.1M | -15.3M |
| Net Income | -52.8M | 50.8M | -15.4M | -160.8M |
| Diluted EPS | $-1.15 | $1.02 | $-0.34 | $-3.49 |
Annual Financials
| Metric | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | 555.5M | 551.5M | 573.4M | 593.8M |
| Gross Profit | 255.6M | 239.2M | 254.6M | 270.3M |
| Operating Income | -23.4M | -56.7M | -39.9M | -21.7M |
| Net Income | 2.1B | -14.6M | -164.9M | -55.8M |
| Diluted EPS | $28.48 | $-0.22 | $-3.60 | $-1.22 |